Home › Research › Getting a diagnosis
Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set
Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, Jicha G, Carlsson C et al.. Alzheimer disease and associated disorders, 2018-10-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Introduction In 2015, the US Alzheimer's Disease Centers (ADC) implemented Version 3 of the Uniform Data Set (UDS). This paper describes the history of Version 3 development and the UDS data that are freely available to researchers. Methods UDS Version 3 was developed after years of coordination between the National Institute on Aging-appointed Clinical Task Force (CTF), clinicians from ∼30 ADCs, and the National Alzheimer's Coordinating Center (NACC). The CTF recognized the need for updates to align with the state of the science in dementia research, while being flexible to the diverse needs and diseases studied at the ADCs. Version 3 also developed a nonproprietary neuropsychological battery. Results This paper focuses on the substantial Version 3 changes to the UDS forms related to clinical diagnosis and characterization of clinical symptoms to match updated consensus-based diagnostic criteria. Between March 2015 and March 2018, 4820 participants were enrolled using UDS Version 3. Longitudinal data were available for 25,337 of the 37,568 total participants using all UDS versions. Discussion The results from utilization of the UDS highlight the possibility for numerous research institutions to successfully collaborate, produce, and use standardized data collection instruments for over a decade.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 4,820 participants. This paper describes Version 3 of a standardized data set used by US Alzheimer's Disease Centers, updated to match current consensus diagnostic criteria, with 4820 participants enrolled using it between 2015 and 2018. It shows that many research institutions can collaborate over a decade to produce and use standardized data collection instruments, which supports research rather than being a treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Besser, L., Kukull, W., Knopman, D. S., Chui, H., Galasko, D., Weintraub, S., et al. (2018). Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer disease and associated disorders. https://doi.org/10.1097/wad.0000000000000279
Vancouver
Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, et al. Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer disease and associated disorders. 2018. doi:10.1097/wad.0000000000000279. PMID: 30376508.
BibTeX
@article{besser2018-30376508,
author = {Besser, L. and Kukull, W. and Knopman, D. S. and Chui, H. and Galasko, D. and Weintraub, S. and Jicha, G. and Carlsson, C. and others},
title = {{Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set}},
journal = {Alzheimer disease and associated disorders},
year = {2018},
doi = {10.1097/wad.0000000000000279},
pmid = {30376508},
url = {https://doi.org/10.1097/wad.0000000000000279}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results This paper focuses on the substantial Version 3 changes to the UDS forms related to clinical diagnosis and characterization of clinical symptoms to match updated consensus-based diagnostic criteria.
- Discussion The results from utilization of the UDS highlight the possibility for numerous research institutions to successfully collaborate, produce, and use standardized data collection instruments for over a decade.
Why it matters
This paper describes Version 3 of a standardized data set used by US Alzheimer's Disease Centers, updated to match current consensus diagnostic criteria, with 4820 participants enrolled using it between 2015 and 2018. It shows that many research institutions can collaborate over a decade to produce and use standardized data collection instruments, which supports research rather than being a treatment or cure.
New to this subject? Start with our plain-English guide: Getting a diagnosis →
Study details
- Study designlongitudinal study
- Participants4,820
- Evidence strengthModerate
How this study scored 73/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer disease and associated disorders) |
| Journal's citation record | 1 / 4 | Alzheimer Disease & Associated Disorders: journal h-index 131 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2018 — within 10 year(s) of the newest study here |
| Sample size | 3 / 4 | 4,820 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 513 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 51.3 citations a year over 10 year(s) since 2018 |
| Impact for its field and year | 4 / 6 | Cited 17.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 37 other studies in this library |
| Still being cited | 4 / 4 | Cited 289 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author John C. Morris: h-index 209 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | University of Washington: institution h-index 3,540 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 16 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 30376508) |
| Free to read | 2 / 2 | Free to read |
| Total | 73 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1097/wad.0000000000000279
- PubMed: 30376508
- Original source →
- Free full text: Alzheimer Disease & Associated Disorders →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.
Later studies that cite this one
37 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Getting a diagnosis from nearby years
Also in Getting a diagnosis
141 studies in the library are filed under Getting a diagnosis with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Getting a diagnosis hub.